Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
Frederike Bensch, Elly L. van der Veen, Marjolijn N. Lub–de Hooge, et al.
Nature Medicine (2018) Vol. 24, Iss. 12, pp. 1852-1858
Closed Access | Times Cited: 606

Showing 1-25 of 606 citing articles:

Lung cancer
Alesha Thai, Benjamin Solomon, Lecia V. Sequist, et al.
The Lancet (2021) Vol. 398, Iss. 10299, pp. 535-554
Closed Access | Times Cited: 1654
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig, Johann von Felden, Teresa García‐Lezana, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 3, pp. 139-152
Closed Access | Times Cited: 678
In vivo molecular imaging for immunotherapy using ultra-bright near-infrared-IIb rare-earth nanoparticles
Yeteng Zhong, Zhuoran Ma, Feifei Wang, et al.
Nature Biotechnology (2019) Vol. 37, Iss. 11, pp. 1322-1331
Open Access | Times Cited: 487
Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond
Luoyan Ai, Antao Xu, Jie Xu
Advances in experimental medicine and biology (2020), pp. 33-59
Closed Access | Times Cited: 382
ImmunoPET: Concept, Design, and Applications
Weijun Wei, Zachary T. Rosenkrans, Jianjun Liu, et al.
Chemical Reviews (2020) Vol. 120, Iss. 8, pp. 3787-3851
Open Access | Times Cited: 364
Overcoming immunotherapy resistance in non-small cell lung cancer (NSCLC) - novel approaches and future outlook
Lena Horvath, Bernard Thienpont, Liyun Zhao, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 197
Immunotherapy in Renal Cell Carcinoma: The Future Is Now
Antoine Deleuze, Judikaël Saout, Frédéric Dugay, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2532-2532
Open Access | Times Cited: 193
Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways
Brita Singers Sørensen, Michael R. Horsman
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 193
Towards individualized therapy for metastatic renal cell carcinoma
Ritesh R. Kotecha, Robert J. Motzer, Martin H. Voss
Nature Reviews Clinical Oncology (2019) Vol. 16, Iss. 10, pp. 621-633
Closed Access | Times Cited: 185
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
George Crișan, Nastasia Sanda Moldovean-Cioroianu, Diana-Gabriela Timaru, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5023-5023
Open Access | Times Cited: 180
Harnessing non-destructive 3D pathology
Jonathan Liu, Adam K. Glaser, Kaustav Bera, et al.
Nature Biomedical Engineering (2021) Vol. 5, Iss. 3, pp. 203-218
Open Access | Times Cited: 110
Radiochemistry for positron emission tomography
Jian Rong, Ahmed Haider, Troels E. Jeppesen, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 110
Near-Infrared-II Nanoparticles for Cancer Imaging of Immune Checkpoint Programmed Death-Ligand 1 and Photodynamic/Immune Therapy
Qiang Liu, Jiangwei Tian, Ye Tian, et al.
ACS Nano (2021) Vol. 15, Iss. 1, pp. 515-525
Closed Access | Times Cited: 107
Advances in PET imaging of cancer
Johannes Schwenck, Dominik Sonanini, Jonathan Cotton, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 7, pp. 474-490
Closed Access | Times Cited: 102
Molecular and functional imaging in cancer-targeted therapy: current applications and future directions
Jing‐Wen Bai, Si-Qi Qiu, Guo‐Jun Zhang
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 93
Whole-body CD8+ T cell visualization before and during cancer immunotherapy: a phase 1/2 trial
Laura Kist de Ruijter, Pim P. van de Donk, Jahlisa S. Hooiveld-Noeken, et al.
Nature Medicine (2022) Vol. 28, Iss. 12, pp. 2601-2610
Open Access | Times Cited: 77
Radiolabeled Antibodies for Cancer Imaging and Therapy
Sagun Parakh, Sze Ting Lee, Hui Gan, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1454-1454
Open Access | Times Cited: 71
Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
Chenyue Zhang, Chenxing Zhang, Haiyong Wang
Cancer Letters (2023) Vol. 562, pp. 216182-216182
Closed Access | Times Cited: 55
Nanoprobe-based molecular imaging for tumor stratification
Xianbin Ma, Mingchuan Mao, Jiaqi He, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 18, pp. 6447-6496
Closed Access | Times Cited: 48
ImmunoPET imaging of Trop2 in patients with solid tumours
Wei Huang, You Zhang, Min Cao, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 5, pp. 1143-1161
Open Access | Times Cited: 15
Recent developments on PET radiotracers for TSPO and their applications in neuroimaging
Lingling Zhang, Kuan Hu, Tuo Shao, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 2, pp. 373-393
Open Access | Times Cited: 121
The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time’s a Charm
Quentin Lecocq, Marleen Keyaerts, Nick Devoogdt, et al.
International Journal of Molecular Sciences (2020) Vol. 22, Iss. 1, pp. 75-75
Open Access | Times Cited: 115
Current Perspectives on 89Zr-PET Imaging
Joon‐Kee Yoon, Bok-Nam Park, Eun-Kyoung Ryu, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4309-4309
Open Access | Times Cited: 113
Cachexia - sarcopenia as a determinant of disease control rate and survival in non-small lung cancer patients receiving immune-checkpoint inhibitors
Benoît Roch, Amandine Coffy, Sandy Jean-Baptiste, et al.
Lung Cancer (2020) Vol. 143, pp. 19-26
Open Access | Times Cited: 112
ICOS Is an Indicator of T-cell–Mediated Response to Cancer Immunotherapy
Zunyu Xiao, Aaron T. Mayer, Tomomi W. Nobashi, et al.
Cancer Research (2020) Vol. 80, Iss. 14, pp. 3023-3032
Open Access | Times Cited: 96
Page 1 - Next Page

Scroll to top